Literature DB >> 26741146

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists.

Mojgan Aghazadeh Tabrizi1, Pier Giovanni Baraldi1, Pier Andrea Borea1, Katia Varani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26741146     DOI： 10.1021/acs.chemrev.5b00411

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  16 in total

Review 1.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694

2.  Development of Quinazoline/Pyrimidine-2,4(1H,3H)-diones as Agonists of Cannabinoid Receptor Type 2.

Authors:  Hai-Yan Qian; Zhi-Long Wang; You-Lu Pan; Li-Li Chen; Xin Xie; Jian-Zhong Chen
Journal:  ACS Med Chem Lett       Date:  2017-05-01       Impact factor: 4.345

3.  Development of Highly Affine and Selective Fluorinated Cannabinoid Type 2 Receptor Ligands.

Authors:  Rareş-Petru Moldovan; Kristin Hausmann; Winnie Deuther-Conrad; Peter Brust
Journal:  ACS Med Chem Lett       Date:  2017-04-28       Impact factor: 4.345

4.  Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers.

Authors:  Yuemin Bian; Yankang Jing; Lirong Wang; Shifan Ma; Jaden Jungho Jun; Xiang-Qun Xie
Journal:  Mol Pharm       Date:  2019-05-03       Impact factor: 4.939

Review 5.  Cannabis for Rheumatic Disease Pain: a Review of Current Literature.

Authors:  William Benjamin Nowell; Kelly Gavigan; Stuart L Silverman
Journal:  Curr Rheumatol Rep       Date:  2022-04-29       Impact factor: 4.686

Review 6.  Mini-review: The therapeutic role of cannabinoids in neuroHIV.

Authors:  Barkha J Yadav-Samudrala; Sylvia Fitting
Journal:  Neurosci Lett       Date:  2021-02-12       Impact factor: 3.046

7.  Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers.

Authors:  Takahiro Doi; Takaomi Tagami; Akihiro Takeda; Akiko Asada; Yoshiyuki Sawabe
Journal:  Forensic Toxicol       Date:  2017-08-04       Impact factor: 4.096

8.  Metal-free hydroarylation of the side chain carbon-carbon double bond of 5-(2-arylethenyl)-3-aryl-1,2,4-oxadiazoles in triflic acid.

Authors:  Anna S Zalivatskaya; Dmitry S Ryabukhin; Marina V Tarasenko; Alexander Yu Ivanov; Irina A Boyarskaya; Elena V Grinenko; Ludmila V Osetrova; Eugeniy R Kofanov; Aleksander V Vasilyev
Journal:  Beilstein J Org Chem       Date:  2017-05-11       Impact factor: 2.883

Review 9.  Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases.

Authors:  Cristina Prandi; Marco Blangetti; Dvora Namdar; Hinanit Koltai
Journal:  Molecules       Date:  2018-06-25       Impact factor: 4.411

Review 10.  Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders.

Authors:  Gemma Navarro; Paula Morales; Carmen Rodríguez-Cueto; Javier Fernández-Ruiz; Nadine Jagerovic; Rafael Franco
Journal:  Front Neurosci       Date:  2016-09-13       Impact factor: 4.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.